Aetram Research India - Nifty Pharma - Weekly Sector Outlook
Aetram Research India - Nifty Pharma - Weekly Sector Outlook
Nifty Pharma Consolidates Near 26,360; Strength Above 26,450 Could Restore Upside, While 26,240 Failure Risks Renewed Sector Weakness - 22.08.2026
Current Market Price: 26,359.75
Market Prediction
- Nifty Pharma is balancing between overhead averages and long-term support, leaving directional control evenly contested. RSI near 50 confirms neutral momentum, while MACD remains marginally negative and ADX at 12.63 signals weak trend strength. Acceptance above 26,450 could revive recovery; below 26,240, weakness may approach 26,050–25,900 over the coming sessions.
Upcoming Events
- Positive Catalyst: New drug approvals and favourable regulatory clearances could strengthen sentiment across pharmaceutical companies.
- Negative Catalyst: Adverse USFDA observations or pricing pressure in major export markets may restrict sector performance.
- Positive/Negative Catalyst: Currency movement, healthcare policy updates and company-specific product launches could influence direction.
Major Support and Resistance
- Support: 26,240, 26,050, 25,900
- Resistance: 26,375, 26,450, 26,650
Volume Analysis
- Volume remains restrained near 4.37 million, matching the sector’s narrow consolidation and absence of firm directional participation. Stronger activity above 26,450 would improve confidence, while expanding supply below 26,240 could disturb long-term support and stability.
Final Take Away
- Pharma’s broader structure remains constructive above 26,250, but immediate momentum is neutral beneath 26,435. The sector needs acceptance above 26,450 to regain leadership; otherwise, sideways movement may continue with selective stock-specific strength across defensive counters.
Next Week Prediction
- Next week, Pharma may consolidate between 26,240 and 26,450; stronger participation above resistance could unlock 26,650, while support failure may invite deeper correction toward 26,050.
Scenario-Based Outlook
- Bullish Scenario: Above 26,450, price may move toward the 26,650–26,850 zone.
- Bearish Scenario: Below 26,240, downside risk toward the 26,050–25,900 zone.
- Neutral Scenario: Between 26,240–26,450, consolidation likely.
Disclaimer: This research report is for informational purposes only. This is not an offer to buy or sell securities. Past performance is not indicative of future results. There is no guarantee of returns. Investments in securities are subject to market risks including loss of capital. Investors should consult their financial advisor before making any investment decisions.
